Common use of Sponsorship Clause in Contracts

Sponsorship. FDA, in furtherance of its tax-exempt purposes, conducts sponsorship opportunities indicated on pages 22 & 23 of the 2022 Exhibitor Prospectus, hereinafter as “Events”. The Events are included in the Florida Dental Convention of the Florida Dental Association. Sponsor desires to sponsor the Events; and FDA desires to permit Sponsor to sponsor the Events on a non-exclusive basis in exchange for certain compensation, during the terms (as defined herein): (a) FDA shall identify and acknowledge Sponsor as a sponsor of the Events, as permitted in connection with qualified sponsorship payments under Section 513(i) of the Internal Revenue Code of 1986, as the same may be amended or supplemented (the “Code”), and the Treasury regulations thereunder. Such identification and acknowledgment shall include displaying Sponsor’s corporate logo and certain other identifying information (as permitted in connection with qualified sponsorship payments under Section 513(i) of the Code and the Treasury regulations thereunder) on the said and applicable Events in connection with the Events, as well as on other appropriate promotional media and materials in connection with the Events. The placement, form, content, appearance, and all other aspects of such identification and acknowledgment shall be determined by FDA in its sole discretion. (b) Sponsor shall provide to FDA, and allow it to use its trademarks, servicemarks, logos and other information, content and materials (in printed, electronic and/or other form) (collectively, the “Sponsor Marks”) in connection with Sponsor’s sponsorship of the Events; provided, however, that all uses of Sponsor’s Marks shall be determined by FDA in its sole discretion and shall be in accordance with Section 2 below.

Sponsorship. FDA, in furtherance of its tax-exempt purposes, conducts sponsorship opportunities indicated on pages 22 & 23 of the 2022 2024 Exhibitor Prospectus, hereinafter as “Events”. The Events are included in the Florida Dental Convention of the Florida Dental Association. Sponsor desires to sponsor the Events; and FDA desires to permit Sponsor to sponsor the Events on a non-exclusive basis in exchange for certain compensation, during the terms (as defined herein): (a) FDA shall identify and acknowledge Sponsor as a sponsor of the Events, as permitted in connection with qualified sponsorship payments under Section 513(i) of the Internal Revenue Code of 1986, as the same may be amended or supplemented (the “Code”), and the Treasury regulations thereunder. Such identification and acknowledgment shall include displaying Sponsor’s corporate logo and certain other identifying information (as permitted in connection with qualified sponsorship payments under Section 513(i) of the Code and the Treasury regulations thereunder) on the said and applicable Events in connection with the Events, as well as on other appropriate promotional media and materials in connection with the Events. The placement, form, content, appearance, and all other aspects of such identification and acknowledgment shall be determined by FDA in its sole discretion. (b) Sponsor shall provide to FDA, and allow it to use its trademarks, servicemarks, logos and other information, content and materials (in printed, electronic and/or other form) (collectively, the “Sponsor Marks”) in connection with Sponsor’s sponsorship of the Events; provided, however, that all uses of Sponsor’s Marks shall be determined by FDA in its sole discretion and shall be in accordance with Section 2 below.

Sponsorship. FDA, in furtherance of its tax-exempt purposesAADSM, conducts sponsorship opportunities indicated on the front pages 22 & 23 of the 2022 Exhibitor Prospectusthis Agreement, hereinafter as “Events”. The Events are included in the Florida Dental Convention Annual Meeting of the Florida American Academy of Dental AssociationSleep Medicine. Sponsor desires to sponsor the Events; and FDA AADSM desires to permit Sponsor to sponsor the Events on a non-exclusive basis in exchange for certain compensation, during . During the terms Term of this Agreement (as defined herein): (a) FDA a. AADSM shall identify and acknowledge Sponsor as a sponsor of the Events, as permitted in connection with qualified sponsorship payments under Section 513(i) of the Internal Revenue Code of 1986, as the same may be amended or supplemented (the “Code”), and the Treasury regulations thereunder. Such identification and acknowledgment shall include displaying Sponsor’s corporate logo and certain other identifying information (as permitted in connection with qualified sponsorship payments under Section 513(i) of the Code and the Treasury regulations thereunder) on the said and applicable Events in connection with the Events, as well as on other appropriate promotional media and materials in connection with the Events. The placement, form, content, appearance, and all other aspects of such identification and acknowledgment shall be determined by FDA AADSM in its sole discretion. (b) b. Sponsor shall provide to FDAAADSM, and allow it to use its trademarks, servicemarks, logos and other information, content and materials (in printed, electronic and/or other form) (collectively, the “Sponsor Marks”) in connection with Sponsor’s sponsorship of the Events; provided, however, that all uses of Sponsor’s Marks shall be determined by FDA AADSM in its sole discretion and shall be in accordance with Section 2 below.

Sponsorship. FDA, in furtherance of its tax-exempt purposes, conducts sponsorship opportunities indicated on pages 22 & 23 of the 2022 2025 Exhibitor ProspectusProspectus , hereinafter as “EventsEvents ”. The Events are included in the Florida Dental Convention of the Florida Dental Association. Sponsor desires to sponsor the EventsEvents ; and FDA desires to permit Sponsor to sponsor the Events on a non-exclusive basis in exchange for certain compensation, during the terms (as defined herein): (a) FDA shall identify and acknowledge Sponsor as a sponsor of the Events, as permitted in connection with qualified sponsorship payments under Section 513(i) of the Internal Revenue Code of 1986, as the same may be amended or supplemented (the “Code”), and the Treasury regulations thereunder. Such identification and acknowledgment shall include displaying Sponsor’s corporate logo and certain other identifying information (as permitted in connection with qualified sponsorship payments under Section 513(i) of the Code and the Treasury regulations thereunder) on the said and applicable Events in connection with the Events, as well as on other appropriate promotional media and materials in connection with the Events. The placement, form, content, appearance, and all other aspects of such identification and acknowledgment shall be determined by FDA in its sole discretion. (b) Sponsor shall provide to FDA, and allow it to use its trademarks, servicemarks, logos and other information, content and materials (in printed, electronic and/or other form) (collectively, the “Sponsor Marks”) in connection with Sponsor’s sponsorship of the Events; provided, however, that all uses of Sponsor’s Marks shall be determined by FDA in its sole discretion and shall be in accordance with Section 2 below.

Sponsorship. FDA, in furtherance of its tax-exempt purposes, conducts sponsorship opportunities indicated on pages 22 & 23 of the 2022 2021 Exhibitor Prospectus, hereinafter as “Events”. The Events are included in the Florida Dental Convention of the Florida Dental Association. Sponsor desires to sponsor the Events; and FDA desires to permit Sponsor to sponsor the Events on a non-exclusive basis in exchange for certain compensation, during the terms (as defined herein): (a) FDA shall identify and acknowledge Sponsor as a sponsor of the Events, as permitted in connection with qualified sponsorship payments under Section 513(i) of the Internal Revenue Code of 1986, as the same may be amended or supplemented (the “Code”), and the Treasury regulations thereunder. Such identification and acknowledgment shall include displaying Sponsor’s corporate logo and certain other identifying information (as permitted in connection with qualified sponsorship payments under Section 513(i) of the Code and the Treasury regulations thereunder) on the said and applicable Events in connection with the Events, as well as on other appropriate promotional media and materials in connection with the Events. The placement, form, content, appearance, and all other aspects of such identification and acknowledgment shall be determined by FDA in its sole discretion. (b) Sponsor shall provide to FDA, and allow it to use its trademarks, servicemarks, logos and other information, content and materials (in printed, electronic and/or other form) (collectively, the “Sponsor Marks”) in connection with Sponsor’s sponsorship of the Events; provided, however, that all uses of Sponsor’s Marks shall be determined by FDA in its sole discretion and shall be in accordance with Section 2 below.

Sponsorship. FDA, in furtherance of its tax-exempt purposesAADSM, conducts sponsorship opportunities indicated on the front pages 22 & 23 of the 2022 Exhibitor Prospectusthis Agreement, hereinafter as “Events”. The Events are included in the Florida Dental Convention Annual Meeting of the Florida American Academy of Dental AssociationSleep Medicine. Sponsor desires to sponsor the Events; and FDA AADSM desires to permit Sponsor to sponsor the Events on a non-exclusive basis in exchange for certain compensation, during . During the terms Term of this Agreement (as defined defined herein): (a) FDA a. AADSM shall identify and acknowledge Sponsor as a sponsor of the Events, as permitted in connection with qualified qualified sponsorship payments under Section 513(i) of the Internal Revenue Code of 1986, as the same may be amended or supplemented (the “Code”), and the Treasury regulations thereunder. Such identification identification and acknowledgment shall include displaying Sponsor’s corporate logo and certain other identifying information (as permitted in connection with qualified qualified sponsorship payments under Section 513(i) of the Code and the Treasury regulations thereunder) on the said and applicable Events in connection with the Events, as well as on other appropriate promotional media and materials in connection with the Events. The placement, form, content, appearance, and all other aspects of such identification identification and acknowledgment shall be determined by FDA AADSM in its sole discretion. (b) b. Sponsor shall provide to FDAAADSM, and allow it to use its trademarks, servicemarks, logos and other information, content and materials (in printed, electronic and/or other form) (collectively, the “Sponsor Marks”) in connection with Sponsor’s sponsorship of the Events; provided, however, that all uses of Sponsor’s Marks shall be determined by FDA AADSM in its sole discretion and shall be in accordance with Section 2 below.